Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.230
-0.145 (-3.31%)
Feb 23, 2026, 2:35 PM CET
Market Cap1.55B +102.3%
Revenue (ttm)100.00K
Net Income-58.91M
EPS-0.22
Shares Out354.14M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,031,860
Average Volume2,002,369
Open4.330
Previous Close4.375
Day's Range4.150 - 4.330
52-Week Range1.804 - 5.490
Beta-0.04
RSI40.44
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 13
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements